Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E G, Boichenko"'
Autor:
J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 37-49 (2022)
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих
Externí odkaz:
https://doaj.org/article/60da326014b14be09d19043fc252c8e4
Autor:
E. G. Boichenko, E. M. Petrova, M. B. Ivanovskaya, I. A. Garbusova, M. B. Belogurova, G. G. Radulesku, Yu. V. Roumiantseva, D. V. Litvinov, S. N. Lagoiko, K. L. Kondratchik, N. I. Ponomareva, N. R. Tukalova, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 12-21 (2022)
Comparative retrospective analysis of treatment results of three different chemotherapy protocols - ALL BFM 90m, ALL MB 91 and PECO 92 — in primary ALL patients aged before 18 years, registered in Moscow and St-Petersburg clinics from 01.01.1993 to
Externí odkaz:
https://doaj.org/article/d12d41e8fa8840ca9152f851f59db814
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Autor:
Yu V Rumyantseva, A I Karachunsky, O V Aleinikova, L G Fechina, A V Shamardina, D V Litvinov, N I Ponomareva, E G Boichenko, S A Dudkin, O V Streneva, K L Kondratchik, E G Mansurova, L M Minkina, E S Lapotentova, E V Inyushkina, N B Yudina, G P Pavlova, E V Zhukovskaya, O P Khlebnikova, S N Lagoiko, E V Basharova, R E Denisov, V D Zlobina, E S Banshchikova, K S Aslanyan, E V Kondakova, E V Tselousova, N V Myakova, T V Turobova, O V Ryskal, N F Chipsanova, S R Varfolomeyeva, A G Rumyantsev
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 11-19 (2010)
Aim. To evaluate the efficiency of the original ALL-MB-2002 protocol within the multicenter study of treatment of acute lymphoblastic leukemia (ALL) in children. Subjects and methods. A total of 1873 primary patients with ALL aged 1 to 18 years, of w
Externí odkaz:
https://doaj.org/article/cfbc2ada713446ef93c73a86b57fd3bc
Autor:
S V, Babak, A A, Korzhenkov, N I, Samarov, E G, Boichenko, M A, Goeva, A Yu, Voloshina, V R, Miftakhova, A N, Pankina
Publikováno v:
Voprosy onkologii. 62(5)
The introduction of acute leukemia chemotherapy programs in clinical practice improved effectiveness of treatment and patients' survival rate. However there is a high incidence of anticancer drugs toxicity leading to a decrease in therapeutic effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::878488e2d6c841f80db93e0ff5b1afcd
https://pubmed.ncbi.nlm.nih.gov/30695583
https://pubmed.ncbi.nlm.nih.gov/30695583